C132H184N32O8 — CID 160970340
3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[4-(dimethylamino)piperidin-1-yl]propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(4-hydroxy-4-phenylpiperidin-1-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(4-methylpiperazin-1-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-morpholin-4-ylpropan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[(3R)-3-phenylpiperidin-1-yl]propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-pyrrolidin-1-ylpropan-1-one (PubChem CID 160970340) has the molecular formula C132H184N32O8 and a molecular weight of 2347.14 g/mol. Its IUPAC name is 3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[4-(dimethylamino)piperidin-1-yl]propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(4-hydroxy-4-phenylpiperidin-1-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(4-methylpiperazin-1-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-morpholin-4-ylpropan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[(3R)-3-phenylpiperidin-1-yl]propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-pyrrolidin-1-ylpropan-1-one.
| Compound Name | 3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[4-(dimethylamino)piperidin-1-yl]propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(4-hydroxy-4-phenylpiperidin-1-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(4-methylpiperazin-1-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-morpholin-4-ylpropan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[(3R)-3-phenylpiperidin-1-yl]propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-pyrrolidin-1-ylpropan-1-one |
|---|---|
| PubChem CID | 160970340 |
| Molecular Formula | C132H184N32O8 |
| Molecular Weight | 2347.14 g/mol |
| Exact Mass | 2345.50 |
| IUPAC Name | 3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[4-(dimethylamino)piperidin-1-yl]propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(4-hydroxy-4-phenylpiperidin-1-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(4-methylpiperazin-1-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-morpholin-4-ylpropan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[(3R)-3-phenylpiperidin-1-yl]propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-pyrrolidin-1-ylpropan-1-one |
| SMILES | CN(C)C1CCN(C(=O)CCc2[nH]nc3ccnc(NC4CCCCC4)c23)CC1.CN1CCN(C(=O)CCc2[nH]nc3ccnc(NC4CCCCC4)c23)CC1.O=C(CCc1[nH]nc2ccnc(NC3CCCCC3)c12)N1CCC(O)(c2ccccc2)CC1.O=C(CCc1[nH]nc2ccnc(NC3CCCCC3)c12)N1CCCC1.O=C(CCc1[nH]nc2ccnc(NC3CCCCC3)c12)N1CCC[C@H](c2ccccc2)C1.O=C(CCc1[nH]nc2ccnc(NC3CCCCC3)c12)N1CCOCC1 |
| InChI | InChI=1S/C26H33N5O2.C26H33N5O.C22H34N6O.C20H30N6O.C19H27N5O2.C19H27N5O/c32-23(31-17-14-26(33,15-18-31)19-7-3-1-4-8-19)12-11-21-24-22(30-29-21)13-16-27-25(24)28-20-9-5-2-6-10-20;32-24(31-17-7-10-20(18-31)19-8-3-1-4-9-19)14-13-22-25-23(30-29-22)15-16-27-26(25)28-21-11-5-2-6-12-21;1-27(2)17-11-14-28(15-12-17)20(29)9-8-18-21-19(26-25-18)10-13-23-22(21)24-16-6-4-3-5-7-16;1-25-11-13-26(14-12-25)18(27)8-7-16-19-17(24-23-16)9-10-21-20(19)22-15-5-3-2-4-6-15;25-17(24-10-12-26-13-11-24)7-6-15-18-16(23-22-15)8-9-20-19(18)21-14-4-2-1-3-5-14;25-17(24-12-4-5-13-24)9-8-15-18-16(23-22-15)10-11-20-19(18)21-14-6-2-1-3-7-14/h1,3-4,7-8,13,16,20,33H,2,5-6,9-12,14-15,17-18H2,(H,27,28)(H,29,30);1,3-4,8-9,15-16,20-21H,2,5-7,10-14,17-18H2,(H,27,28)(H,29,30);10,13,16-17H,3-9,11-12,14-15H2,1-2H3,(H,23,24)(H,25,26);9-10,15H,2-8,11-14H2,1H3,(H,21,22)(H,23,24);8-9,14H,1-7,10-13H2,(H,20,21)(H,22,23);10-11,14H,1-9,12-13H2,(H,20,21)(H,22,23)/t;20-;;;;/m.0..../s1 |
| InChIKey | SYDZGOKYRNLXPU-QCGISWEWSA-N |
| XLogP | 20.53 |
| TPSA | 479.40 Ų |
| H-Bond Donors | 13 |
| H-Bond Acceptors | 28 |
| Rotatable Bonds | 33 |
| Heavy Atoms | 172 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2347.14 |
| LogP ≤ 5 | 20.53 |
| H-Bond Donors ≤ 5 | 13 |
| H-Bond Acceptors ≤ 10 | 28 |